Background Serum alpha-fetoprotein (AFP) is frequently used to predict posthepatectomy
outcomes in patients with hepatocellular carcinoma (HCC), but its predictive value is still not …

Introduction Although preoperative α-fetoprotein (AFP) has been recognized as an important
tumor marker among patients with hepatocellular carcinoma (HCC), the predictive value of …

Background While the majority of studies report that a raised serum α-fetoprotein (AFP) level
before operation is associated with a high risk of recurrence and death in patients who …

Background The value of alpha-fetoprotein (AFP) as a prognostic indicator in patients with
hepatocellular carcinoma (HCC) has been proposed in recent studies, but the evidence so …

Aim It has been highly controversial whether elevated serum α‐fetoprotein (AFP) level
before hepatectomy predicts recurrence and mortality of patients with hepatocellular …

AIM To investigate whether the change in pre-/post-operation serum alpha-fetoprotein (AFP)
levels is a predictive factor for hepatocellular carcinoma (HCC) outcomes. METHODS We …

Introduction Alpha‐fetoprotein (AFP) has a valuable role in postoperative surveillance for
hepatocellular carcinoma (HCC) recurrence. The utility of pretreatment or baseline AFP …

Objective: To explore the prognostic value of the postsurgical half-life (HL) of serum alpha-
fetoprotein (AFP). Background: There is still a paucity of early surrogate indicators of clinical …

Background Preoperative α-fetoprotein (AFP) level levels may help select patients with
hepatocellular carcinoma (HCC) for surgery. The objective of the current study was to …

UICC staging) and tumor size. Although this study is retrospective, it is of interest both by the
issue raised which is still contradictory and by the large size of the cohort studied by the …